Wolverine Trading, LLC Infinity Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.46 - $1.21 $460 - $1,210	-1,000 Reduced 4.05%	23,700 $13,000
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.7 $14,573 - $41,990	24,700 New	24,700 $29,000
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $9,359 - $22,920	-19,100 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.85 - $2.4 $29,070 - $82,080	-34,200 Reduced 64.17%	19,100 $22,000
Q4 2021 Feb 14, 2022	BUY	$1.86 - $3.36 $99,138 - $179,088	53,300 New	53,300 $125,000
Q3 2021 Nov 12, 2021	SELL	$1.52 - $3.82 $53,808 - $135,228	-35,400 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$2.66 - $3.47 $17,024 - $22,208	6,400 Added 22.07%	35,400 $110,000
Q1 2021 May 14, 2021	BUY	$1.98 - $5.36 $20,592 - $55,744	10,400 Added 55.91%	29,000 $88,000
Q4 2020 Feb 12, 2021	BUY	$1.05 - $2.77 $19,530 - $51,522	18,600 New	18,600 $41,000
Q1 2019 May 15, 2019	SELL	$1.18 - $1.91 $34,810 - $56,345	-29,500 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.01 - $2.78 $7,979 - $21,962	7,900 Added 36.57%	29,500 $35,000
Q3 2018 Nov 14, 2018	SELL	$1.72 - $2.71 $7,912 - $12,466	-4,600 Reduced 17.56%	21,600 $59,000
Q1 2018 May 15, 2018	SELL	$1.8 - $2.74 $10,260 - $15,618	-5,700 Reduced 17.87%	26,200 $55,000
Q4 2017 Feb 14, 2018	BUY	$1.22 - $3.73 $38,918 - $118,987	31,900	31,900 $65,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.